Rossari Biotech Stock Screener | Share Price & Fundamental Analysis
ROSSARI
Specialty Chemicals
Share Price NSE
₹452.20
▲
8.15 (1.84%)
Share Price BSE
₹451.35
▲
7.05 (1.59%)
Track Rossari Biotech share price live with TickJournal's free stock screener.
Analyze Rossari Biotech share price history trends and compare 52-week high low
levels.
Record your trades in TickJournal's free trading journal and track your portfolio performance.
Rossari Biotech Market Cap
₹2,370.96 Cr.
ROSSARI P/E Ratio (TTM)
16.23
Rossari Biotech P/B Ratio
1.79
EPS (TTM)
₹24.66
Dividend Yield
0.12%
Debt to Equity
0.15
ROSSARI 52 Week High
₹743.30
Rossari Biotech 52 Week Low
₹378.60
Operating Margin
12.00%
Profit Margin
5.66%
ROSSARI Revenue (TTM)
₹583.00
EBITDA
₹70.00
Net Income
₹33.00
Total Assets
₹1,896.00
Total Equity
₹1,185.00
Rossari Biotech Share Price History - Stock Screener Chart
Screen ROSSARI historical share price movements with interactive charts. Analyze price trends and patterns.
Rossari Biotech Company Profile - Fundamental Screener
Screen Rossari Biotech company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics
for ROSSARI shares.
Sector
Chemicals
Industry
Specialty Chemicals
Sub-Sector
Specialty Chemicals
Segment
E
ISIN
INE02A801020
Rossari Biotech Balance Sheet Screener
Screen ROSSARI balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation
metrics.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Total Assets | 1,896 | 1,572 | 1,368 | 1,257 | 561 | 472 | 250 |
| Current Assets | 1,042 | 844 | 720 | 609 | 355 | 326 | 160 |
| Fixed Assets | 598 | 578 | 585 | 607 | 181 | 94 | 74 |
| Liabilities | |||||||
| Total Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Liabilities | 174 | 100 | 104 | 157 | 2 | 36 | 4 |
| Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Shareholders' Equity | |||||||
| Total Equity | 1,185 | 1,048 | 915 | 805 | 409 | 287 | 124 |
| Share Capital | 11 | 11 | 11 | 11 | 10 | 10 | 4 |
| Reserves & Surplus | 1,174 | 1,037 | 904 | 794 | 398 | 277 | 119 |
Rossari Biotech Income Statement Screener - Profit & Revenue Analysis
Screen Rossari Biotech income statement and profit fundamentals.
Analyze ROSSARI quarterly results,
revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Rossari Biotech share price evaluation.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar | 2023-Mar | 2023-Jun | 2023-Sept | 2023-Dec | 2022-Mar | 2022-Jun | 2022-Sept |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 583 | 588 | 545 | 582 | 514 | 499 | 491 | 473 | 410 | 413 | 485 | 467 | 442 | 436 | 426 |
| Expenses | 513 | 514 | 476 | 510 | 448 | 432 | 425 | 409 | 352 | 353 | 420 | 400 | 387 | 377 | 369 |
| EBITDA | 70 | 74 | 70 | 71 | 66 | 67 | 66 | 64 | 58 | 60 | 65 | 67 | 56 | 59 | 58 |
| Operating Profit % | 12.00% | 12.00% | 12.00% | 12.00% | 13.00% | 13.00% | 13.00% | 13.00% | 13.00% | 14.00% | 13.00% | 14.00% | 12.00% | 13.00% | 13.00% |
| Depreciation | 20 | 18 | 18 | 18 | 18 | 15 | 15 | 16 | 16 | 14 | 15 | 15 | 17 | 15 | 16 |
| Interest | 8 | 6 | 6 | 6 | 5 | 4 | 4 | 3 | 4 | 6 | 5 | 4 | 5 | 5 | 8 |
| Profit Before Tax | 43 | 50 | 46 | 48 | 42 | 48 | 47 | 46 | 37 | 40 | 45 | 48 | 34 | 39 | 34 |
| Tax | 10 | 13 | 13 | 13 | 11 | 13 | 12 | 11 | 8 | 10 | 12 | 13 | 10 | 10 | 10 |
| Net Profit | 33 | 37 | 34 | 34 | 32 | 35 | 35 | 34 | 29 | 29 | 33 | 34 | 24 | 29 | 24 |
| EPS | 5.92 | 6.66 | 6.07 | 6.22 | 5.73 | 6.39 | 6.32 | 6.18 | 5.25 | 5.30 | 5.97 | 6.23 | 4.37 | 5.21 | 4.34 |
Rossari Biotech Cash Flow Screener - Liquidity Fundamentals
Screen ROSSARI cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price
strength assessment.
| Item | 2025-March | 2024-March | 2023-March | 2022-March | 2021-March | 2020-March | 2019-March |
|---|---|---|---|---|---|---|---|
| Operating Activities | 137 | 43 | 152 | 29 | 48 | 57 | 71 |
| Investing Activities | -183 | -104 | -181 | -299 | -37 | -190 | -37 |
| Financing Activities | 65 | 16 | 61 | 292 | -25 | 157 | -29 |
| Net Cash Flow | 19 | -44 | 32 | 22 | -14 | 24 | 5 |
Rossari Biotech Shareholding Pattern Screener
See Rossari Biotech shareholding pattern with promoter, FII, and DII holdings.
Check Rossari Biotech promoter holding and ownership changes for ROSSARI on TickJournal.
| Item | 2025-Dec | 2025-Sept | 2025-Jun | 2025-Mar | 2024-Dec | 2024-Sept | 2024-Jun | 2024-Mar |
|---|---|---|---|---|---|---|---|---|
| Promoter Holding | 68.16% | 68.17% | 68.17% | 68.18% | 68.19% | 68.27% | 68.32% | 68.32% |
| FII Holding | 2.33% | 2.69% | 3.48% | 3.98% | 3.74% | 3.74% | 3.83% | 4.03% |
| DII Holding | 18.26% | 18.18% | 17.84% | 17.59% | 17.47% | 17.34% | 16.87% | 17.75% |
| Govt Holding | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Public Holding | 9.89% | 9.47% | 9.44% | 9.20% | 9.51% | 9.57% | 9.96% | 9.14% |
| Other Holding | 1.37% | 1.48% | 1.07% | 1.05% | 1.09% | 1.09% | 1.02% | 0.76% |
| Shareholder Count | 89,249 | 91,387 | 91,791 | 92,852 | 95,735 | 97,188 | 100,475 | 98,859 |
Rossari Biotech Share Dividend Screener - Share Yield Analysis
Check Rossari Biotech dividend history with payout and yield data.
View Rossari Biotech dividend details including ex-dates and amounts for ROSSARI stock.
| Period | Dividend Per Share | Dividend Yield |
|---|---|---|
| 2026-March | ₹0.00 | 0.00% |
| 2025-March | ₹0.50 | 0.13% |
| 2024-March | ₹0.50 | 0.08% |
| 2023-March | ₹0.50 | 0.07% |
| 2022-March | ₹0.50 | 0.08% |
| 2021-March | ₹0.50 | 0.05% |
| 2020-March | ₹0.50 | 0.05% |
| 2019-March | ₹0.00 | 0.00% |
| 2018-March | ₹0.00 | 0.00% |
| 2017-March | ₹0.00 | 0.00% |
Rossari Biotech Stock Index Membership
See which indices include Rossari Biotech stock.
Check ROSSARI index membership in NIFTY 50, SENSEX, and other indices on TickJournal.
BSE 1000
BSE INDEX CARBON
BSE INDEX SMLCAP
NIFTY MICROCAP250
NIFTY TOTAL MKT
Rossari Biotech Market Events Screener - Corporate Actions
Get Rossari Biotech corporate actions including splits, bonuses, and buybacks.
Check Rossari Biotech stock events that may affect ROSSARI share price.
| Announcement Date | Record Date | Event Type | Information | Price Impact |
|---|---|---|---|---|
| Dividend | ₹ 0.50 /share | 10.89% | ||
| 2026-01-17 | 2026-01-17 | Quarterly Result Announcement | NA | -5.38% |
| 2025-10-15 | 2025-10-15 | Quarterly Result Announcement | NA | 2.97% |
| 2025-07-19 | 2025-07-19 | Quarterly Result Announcement | NA | 6.09% |
| 2025-06-30 | 2025-06-30 | Annual General Meeting | NA | 2.20% |
| 2025-06-20 | 2025-06-20 | Dividend | ₹ 0.50 /share | -5.99% |
| 2025-04-25 | 2025-04-25 | Quarterly Result Announcement | NA | 2.48% |
| 2025-01-21 | 2025-01-21 | Quarterly Result Announcement | NA | -0.71% |
| 2024-11-11 | 2024-11-11 | Extraordinary General Meeting | NA | -6.62% |
| 2024-10-19 | 2024-10-19 | Quarterly Result Announcement | NA | 2.55% |
| 2024-08-23 | 2024-08-23 | Annual General Meeting | NA | 13.57% |
| 2024-08-16 | 2024-08-16 | Dividend | ₹ 0.50 /share | 18.00% |
| 2023-05-24 | 2023-05-24 | Dividend | ₹ 0.50 /share | 3.22% |
| 2022-07-07 | 2022-07-08 | Dividend | ₹ 0.50 /share | -3.11% |
Rossari Biotech Competitors Screener - Peer Comparison
Screen ROSSARI competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better
stock selection.
| Company | Market Cap | P/E Ratio | Revenue | YoY Growth | Net Profit | RSI |
|---|---|---|---|---|---|---|
| Pidilite Industries | 129,623 | 57.43 | 13,388 | 6.91% | 2,096 | 35.70 |
| SRF | 71,619 | 42.58 | 14,826 | 12.13% | 1,251 | 42.38 |
| Gujarat Fluorochemicals | 35,190 | 54.08 | 4,853 | 10.61% | 546 | 48.86 |
| Navin Fluorine International | 30,181 | 56.61 | 2,393 | 12.83% | 289 | 41.36 |
| Himadri Speciality Chemical | 22,611 | 32.10 | 4,664 | 10.33% | 555 | 47.68 |
| Deepak Nitrite | 18,791 | 34.59 | 8,366 | 7.84% | 697 | 42.30 |
| Atul | 18,537 | 31.10 | 5,692 | 18.99% | 499 | 49.36 |
| Aarti Industries | 14,819 | 39.48 | 7,285 | 14.16% | 331 | 45.77 |
| Aether Industries | 14,639 | 68.56 | 880 | 38.11% | 158 | 54.57 |
| Anupam Rasayan | 14,406 | 63.43 | 1,449 | -3.77% | 160 | 51.59 |
Rossari Biotech Company Announcements - News Screener
Screen ROSSARI latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
| Date | Update | Actions |
|---|---|---|
| 2026-04-08 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015. | - |
| 2026-04-08 | Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 | - |
| 2026-04-05 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-03-30 | Closure of Trading Window | - |
| 2026-03-24 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-02-18 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 | - |
| 2026-02-02 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-29 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) 2015 | - |
| 2026-01-23 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) 2015 | - |
| 2026-01-23 | Announcement under Regulation 30 (LODR)-Earnings Call Transcript | - |
| 2026-01-19 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | - |
| 2026-01-19 | Announcement under Regulation 30 (LODR)-Press Release / Media Release | - |
| 2026-01-18 | Announcement under Regulation 30 (LODR)-Investor Presentation | - |
| 2026-01-18 | Announcement under Regulation 30 (LODR)-Newspaper Publication | - |
| 2026-01-17 | Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. | - |
| 2026-01-17 | Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS | - |
| 2026-01-17 | Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Nine Months Ended December 31 2025. | - |
| 2026-01-17 | Board Meeting Outcome for Outcome Of Board Meeting Held On January 17 2026. | - |
| 2026-01-13 | Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | - |
| 2026-01-09 | Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Nine Months Ended December 31 2025. | - |